|
|
| Line 3: |
Line 3: |
| == Function == | | == Function == |
|
| |
|
| '''Complement C5''' (CC5) is the fifth component of the complement system. The complement system is part of the innate immune system. CC5 is composed of α chain (C5a) and β chain (C5b). Proteoplytic degradation of CC5 produces '''anaphylatoxin''' which is a mediator of local inflammatory process. The C terminal domain of CC5 (residues 1530-1676) is homologous to a domain in netrins and is named '''C345C'''. Activation of CC5 by C5 convertase initiates the assembly of the C5 to C9 components into the membrane attack complex. <ref>PMID:18536718</ref> | | '''Complement C5''' (CC5) is the fifth component of the complement system. The complement system is part of the innate immune system. CC5 is composed of α chain (C5a) and β chain (C5b). Proteoplytic degradation of CC5 produces <scene name='70/705685/Cv/3'>anaphylatoxin</scene> which is a mediator of local inflammatory process. The C terminal domain of CC5 (residues 1530-1676) is homologous to a domain in netrins and is named <scene name='70/705685/Cv/3'>C345C</scene>. Activation of CC5 by C5 convertase initiates the assembly of the C5 to C9 components into the membrane attack complex. <ref>PMID:18536718</ref> |
|
| |
|
| == Disease == | | == Disease == |
Revision as of 12:07, 20 December 2015
|
Function
Complement C5 (CC5) is the fifth component of the complement system. The complement system is part of the innate immune system. CC5 is composed of α chain (C5a) and β chain (C5b). Proteoplytic degradation of CC5 produces anaphylatoxin which is a mediator of local inflammatory process. The C terminal domain of CC5 (residues 1530-1676) is homologous to a domain in netrins and is named C345C. Activation of CC5 by C5 convertase initiates the assembly of the C5 to C9 components into the membrane attack complex. [1]
Disease
Mutations in CC5 cause a deficiency leading to severe recurrent infections and are linked to liver fibrosis, Leiner's disease and rheumatoid arthritis.
- ↑ Fredslund F, Laursen NS, Roversi P, Jenner L, Oliveira CL, Pedersen JS, Nunn MA, Lea SM, Discipio R, Sottrup-Jensen L, Andersen GR. Structure of and influence of a tick complement inhibitor on human complement component 5. Nat Immunol. 2008 Jul;9(7):753-60. Epub 2008 Jun 8. PMID:18536718 doi:10.1038/ni.1625
|
3D Structures of complement C5
Updated on 20-December-2015
{"openlevels":0}
- CC5
- 3cu7 – hCC5 – human
- 3kls, 3km9 – hCC5 + exotoxin 1
- 3pvm – hCC5 + cobra venom factor
- 3prx – hCC5 + cobra venom factor + SSL7
- 4a5w, 4e0s – hCC5 + CC6
- C345C
- 1xwe – hCC5 (mutant) - NMR
- C5a anaphylatoxin
References
proteopedia link